Compare · CNMD vs ELMD
CNMD vs ELMD
Side-by-side comparison of CONMED Corporation (CNMD) and Electromed Inc. (ELMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and ELMD operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CNMD is the larger of the two at $1.38B, about 7.3x ELMD ($190.1M).
- ELMD has been more active in the news (7 items in the past 4 weeks vs 6 for CNMD).
- CNMD has more recent analyst coverage (16 ratings vs 3 for ELMD).
- Company
- CONMED Corporation
- Electromed Inc.
- Price
- -
- -
- Market cap
- $1.38B
- $190.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- AMEX
- IPO
- 1987
- 2011
- News (4w)
- 6
- 7
- Recent ratings
- 16
- 3
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Electromed Inc.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Latest CNMD
- Amendment: SEC Form SCHEDULE 13G/A filed by CONMED Corporation
- General Counsel & Corp Sec Foust Hollie K converted options into 4,000 shares and covered exercise/tax liability with 1,124 shares, increasing direct ownership by 100% to 5,762 units (SEC Form 4)
- CONMED Corporation to Participate in the Jefferies Global Healthcare Conference
- SEC Form 10-Q filed by CONMED Corporation
- SEC Form 8-K filed by CONMED Corporation
- CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
- CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
- Director Kelderman Kim converted options into 500 shares (SEC Form 4)
- CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
- SEC Form 10-Q filed by CONMED Corporation
Latest ELMD
- BetterInvesting™ Magazine Update on Electromed Inc. and Five Below Inc.
- SEC Form S-8 filed by Electromed Inc.
- Electromed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by Electromed Inc.
- Electromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Electromed, Inc. Delivers Continued Growth in Fiscal 2027 First Quarter
- Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026
- SEC Form DEF 14A filed by Electromed Inc.
- SEC Form DEFA14A filed by Electromed Inc.
- Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event